Open Access
| Issue |
Med Sci (Paris)
Volume 40, Number 8-9, Août-Septembre 2024
|
|
|---|---|---|
| Page(s) | 613 - 615 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2024088 | |
| Published online | 20 September 2024 | |
- Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 2015 ; 372 : 320–30. [CrossRef] [PubMed] [Google Scholar]
- Herbst RS, Baas P, Kim D-W, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial. Lancet Lond Engl 2016 ; 387 : 1540–50. [CrossRef] [Google Scholar]
- Armand P, Shipp MA, Ribrag V, et al. Programmed death-1 blockade with Pembrolizumab in patients with classical Hodgkin lymphoma after Brentuximab Vedotin failure. J Clin Oncol 2016 ; 34 : 3733–9. [CrossRef] [PubMed] [Google Scholar]
- Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science 2018 ; 359 : 1350–5. [Google Scholar]
- Arlauckas SP, Garris CS, Kohler RH, et al. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med 2017 ; 9 : eaal3604. [CrossRef] [PubMed] [Google Scholar]
- Oh SA, Wu D-C, Cheung J, et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nat Cancer 2020 ; 1 : 681–91. [CrossRef] [PubMed] [Google Scholar]
- Sade-Feldman M, Yizhak K, Bjorgaard SL, et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 2018 ; 175 : 998–1013.e20. [CrossRef] [PubMed] [Google Scholar]
- Siddiqui I, Schaeuble K, Chennupati V, et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 2019 ; 50 : 195–211.e10. [CrossRef] [PubMed] [Google Scholar]
- Spitzer MH, Carmi Y, Reticker-Flynn NE, et al. Systemic immunity is required for effective cancer immunotherapy. Cell 2017 ; 168 : 487–502.e15. [CrossRef] [PubMed] [Google Scholar]
- Wu TD, Madireddi S, de Almeida PE, et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature 2020 ; 579 : 274–8. [CrossRef] [PubMed] [Google Scholar]
- Ruggiu M, Guérin MV, Corre B, et al. Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boosT CD8 T cell responses in tumor-draining lymph nodes. J Exp Med 2024 ; 221 : e20232104. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.